Exact Mass: 370.1654394
Exact Mass Matches: 370.1654394
Found 500 metabolites which its exact mass value is equals to given mass value 370.1654394
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Calanolide
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
6-linalyl-2-O,3-dimethylflaviolin
A hydroxy-1,4-naphthoquinone that is 2-O-methylflaviolin in which the hydrogens at positions 3 and 6 are replaced by methyl and linalyl groups respectively.
7-O-Geranyl-2-O,3-dimethylflaviolin
A hydroxy-1,4-naphthoquinone that is 3-methylflaviolin in which the hydroxyl hydrogens at positions 2 and 7 are replaced by methyl and geranyl groups respectively.
(S)-1-hydroxy-N-methylcanadine
A quaternary ammonium ion that is (S)-N-methylcanadine in which the hydrogen at position 14 is substituted by a hydroxy group.
thioridazine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Thioridazine
A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618) N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Licarin C
Licarin C is found in herbs and spices. Licarin C is isolated from nutmeg. Isolated from nutmeg. Licarin C is found in herbs and spices.
Androsterone sulfate
C19H30O5S (370.18138500000003)
Androsterone sulfate (Andros-S) is the most abundant 5-alpha-reduced androgen metabolite in serum (PMID: 8380602). Androsterone sulfate is clinically recognized as one of the major androgen metabolites found in urine. It is a cognate substrate for human dehydroepiandrosterone sulfotransferase, which catalyzes the transfer of the sulfonate group from 3-phosphoadenosine-5-phosphosulfate to dehydroepiandrosterone (DHEA) (PMID: 14573603). Androsterone sulfate has been identified in the human placenta (PMID: 32033212). Serum dehydroepiandrosterone-sulfate is a classic marker for adrenarche and, subsequently, for the individual hormonal milieu. (PMID 10599744) Dehydroepiandrosterone sulfate is an endogenously produced sex steroid that has been hypothesized to have anti aging effects. (PMID 16960027) It also has been inversely associated with development of atherosclerosis. (PMID 8956025) [HMDB] D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Kanzonol R
Kanzonol R is found in herbs and spices. Kanzonol R is a constituent of Glycyrrhiza glabra (licorice). Constituent of Glycyrrhiza glabra (licorice). Kanzonol R is found in tea and herbs and spices.
5a-Dihydrotestosterone sulfate
C19H30O5S (370.18138500000003)
5a-Dihydrotestosterone sulfate is a sulfate derivative of 5a-Dihydrotestosterone produced through phase II metabolism. 5a-dihydrotestosterone (DHT) is a steroid similar to testosterone and androstenedione, that belongs to a class called androgens. DHT is a C19 steroid and possesses androgenic activity. Androgen production takes place mainly in the Leydig cells of the testes. Androgens circulate in the blood bound to proteins, especially sex hormone binding globulin (SHBG) and albumin. A trace amount of these steroids circulate in the unbound form in the blood and are referred to as the free fractions. DHT has at least three times the binding affinity for SHBG than testosterone. About 70\\% of DHT is derived from peripheral conversion of testosterone in males, while most of the DHT is derived from androstenedione in females. (http://www.biosupply.co.uk/doc.php?id=2296) [HMDB] 5a-Dihydrotestosterone sulfate is a sulfate derivative of 5a-Dihydrotestosterone produced through phase II metabolism. 5a-dihydrotestosterone (DHT) is a steroid similar to testosterone and androstenedione, that belongs to a class called androgens. DHT is a C19 steroid and possesses androgenic activity. Androgen production takes place mainly in the Leydig cells of the testes. Androgens circulate in the blood bound to proteins, especially sex hormone binding globulin (SHBG) and albumin. A trace amount of these steroids circulate in the unbound form in the blood and are referred to as the free fractions. DHT has at least three times the binding affinity for SHBG than testosterone. About 70\\% of DHT is derived from peripheral conversion of testosterone in males, while most of the DHT is derived from androstenedione in females.
Etiocholanolone sulfate
C19H30O5S (370.18138500000003)
Etiocholanolone sulfate is urinary sulfate metabolite of etiocholanolone which is one of the steroid hormone. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
Cellulose, microcrystalline
Cellulose, microcrystalline is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients D001697 - Biomedical and Dental Materials
Lorcainide
C22H27ClN2O (370.18118020000003)
Cardiac dysrhythmia is a heart rate disorder that manifests as an altered cardiac rhythm. It results from either abnormal pacemaker activity or a disturbance in impulse propagation, or both. Arrhythmias can be caused by various conditions including ischemia, hypoxia, pH disruptions, B adrenergic activation, drug interactions or the presence of diseased tissue. These events can trigger the development of ectopic pacemaker in the heart, which emit abnormal impulses at random times during the cardiac cycle. An arrhythmia can present itself as either bradycardia or tachycardia. Untreated arrhythmias may progress to atrial fibrillation or ventricular fibrillation. Treatment is aimed at normalizing cardiac rhythm by altering ion flow across the membrane. Antiarrhythmic agents can reduce arrhythmia related symptoms such as palpitations or syncope; however, they often have a narrow therapeutic index and can also be proarrhythmic. Lorcainide (Lorcainide hydrochloride) is a Class 1c antiarrhythmic agent that is used to help restore normal heart rhythm and conduction in patients with premature ventricular contractions, ventricular tachycardiac and Wolff-Parkinson-White syndrome. Lorcainide was developed by Janssen Pharmaceutica (Belgium) in 1968 under the commercial name Remivox and is designated by code numbers R-15889 or Ro 13-1042/001. It has a half-life of 8.9 +- 2.3 hrs which may be prolonged to 66 hrs in people with cardiac disease. Wolff-Parkinson-White syndrome (WPW) is a pre-excitation syndrome in which individuals are predisposed to supraventricular tachyarrhythmias (rapid and irregular heart beats). People with this condition have an extra or accessory atrioventricular conduction pathway that causes re-entry tachycardia. WPW is characterized by a short PR interval (<0.12 second) and a prolonged, slurred QRS complex (>0.12 seconds). C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Epiandrosterone sulfate
C19H30O5S (370.18138500000003)
Epiandrosterone sulfate, also known as (3beta,5alpha)-17-oxoandrostan-3-yl hydrogen sulfate or epiandrosterone sulphuric acid, is a member of the class of compounds known as sulfated steroids. Sulfated steroids are sterol lipids containing a sulfate group attached to the steroid skeleton. Epiandrosterone sulfate is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). Epiandrosterone sulfate can be synthesized from 5alpha-androstane and synthesized into epiandrosterone. Epiandrosterone sulfate can be found in blood and feces. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
4-Androsten-3beta,17beta-diol 3-sulfate
C19H30O5S (370.18138500000003)
4-Androsten-3beta,17beta-diol 3-sulfate, also known as androstenediol 3-sulfate, is classified as a member of the sulfated steroids. Sulfated steroids are sterol lipids containing a sulfate group attached to the steroid skeleton. 4-Androsten-3beta,17beta-diol monosulfate was found to be significantly (Bonferroni) associated with rheumatoid arthritis (PMID: 28831053).
4-Androsten-3beta,17beta-diol 17-sulfate
4-Androsten-3beta,17beta-diol 17-sulfate, also known as androstenediol 17-sulfate, is classified as a member of the sulfated steroids. Sulfated steroids are sterol lipids containing a sulfate group attached to the steroid skeleton. 4-Androsten-3beta,17beta-diol monosulfate was found to be significantly (Bonferroni) associated with rheumatoid arthritis (PMID: 28831053).
Apabetalone
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2,7-Di-tert-butyl-9-fluorenylmethyl chloroformate
Androstenediol 3-sulfate
C19H30O5S (370.18138500000003)
1-[4-(Cyclooctylamino)pyridin-3-yl]sulfonyl-3-ethylthiourea
Brivanib
Calanolide A
Methyl (3R,3'S,8'S,10'R)-2-oxospiro[1H-indole-3,12'-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7'-carboxylate
N-Desethyl Sunitinib
C20H23FN4O2 (370.18049499999995)
[(3S,8R,9S,10S,13S,14S)-10,13-Dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl] hydrogen sulfate
C19H30O5S (370.18138500000003)
Telenzepine
(3R)-3,4-Dihydro-3-(3-hydroxy-2,4-dimethoxyphenyl)-8-(3-methyl-2-butenyl)-2H-1-benzopyran-7-ol
Unanisoflavan
(S)-4-(4-Hydroxyphenyl)-2-butanol 2-O-(6-O-acetyl)-??-D-glucopyranoside
5,5,6-Trimethyl-6-(1,2,3-triacetoxy-butyl)-5,6-dihydro-pyran-2-on|5,5,6-trimethyl-6-(1,2,3-triacetoxy-butyl)-5,6-dihydro-pyran-2-one
Tri-Ac-5, 6-Dihydro-6-(2, 4, 6-trihydroxyheptyl)-2H-pyran-2-one
3,4-Dimethoxy-3,4-methylenedioxy-7,9-epoxylignan-9-ol
Benzoyl-(+)-3-Hydroxyestra-1,3,5,7,9-pentaen-17-one
8-hydroxy-5-methyl-7-(3-methylbut-2-enyl)-9-(2-methyl-1-oxobutyl)-4,5-dihydropyrano[4,3,2-de]chromen-2-one
7-geranyloxy-5-hydroxy-2-methoxy-6-methyl-1,4-naphthoquinone|flaviogeranin
3-(2,4-Dimethoxy-5-(1,1-dimethylallyl)phenyl)-3,4-dihydro-2H-1-benzopyran-7,8-diol
(?)-2-(3-cyanomethyl-4-methoxy-1H-indol-7-yl)-2-(4-methoxy-1H-indol-3-yl)acetonitrile
C22H18N4O2 (370.14296879999995)
5-Hydroxy-8,8-dimethyl-6-(3-methyl-1-oxobutyl)-4-propyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-2-one|5-hydroxy-8,8-dimethyl-6-(3-methyl-butyryl)-4-propyl-8H-pyrano[2,3-f]chromen-2-one
3-O-acetyl-4,5-O(2-methylbutyryl)-and propionylshikimic acid methyl ester|3-O-acetyl-4,5-O<2-methylbutyryl>-and propionylshikimic acid methyl ester
3-(3-Hydroxy-2,4-dimethoxyphenyl)-7-hydroxy-3,4-dihydro-8-(3-methyl-2-butenyl)-2H-1-benzopyran
(2Z,4E)-2-(3,4-dimethoxybenzylidene)-5-(3,4-dimethoxyphenyl)pent-4-en-1-ol|morinol I
(E)-4-(3,4-dimethoxyphenyl)but-3-en-1-O-beta-D-glucopyranoside|(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-O-??-D-glucopyranoside
4-hydroxy-2-[(E)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl beta-D-glucopyranoside|4-Hydroxy-2-[(E)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl ??-D-glucopyranoside
2-O-Methyl-4-O-(6-methyl-beta-D-galaktopyranosyl)-D-galaktose
8-hydroxy-5-methyl-7-(3-methylbut-2-enyl)-9-(3-methyl-1-oxobutyl)-4,5-dihydropyrano[4,3,2-de]chromen-2-one
2-(1-propionylaminoethyl)thiazole-4-carboxylic acid [2-(1h-indol-3-yl)ethyl]amide
16-phenoxy tetranor Prostaglandin A2
GlyasperinD
Glyasperin D is a member of the class of hydroxyisoflavans that is (R)-isoflavan substituted by hydroxy groups at positions 2 and 4, methoxy groups at positions 5 and 7 and a prenyl group at position 6. It has been isolated from Glycyrrhiza uralensis. It has a role as a plant metabolite. It is a member of hydroxyisoflavans, an aromatic ether and a methoxyisoflavan. Glyasperin D is a natural product found in Glycyrrhiza uralensis and Glycyrrhiza aspera with data available. See also: Glycyrrhiza uralensis Root (part of). A member of the class of hydroxyisoflavans that is (R)-isoflavan substituted by hydroxy groups at positions 2 and 4, methoxy groups at positions 5 and 7 and a prenyl group at position 6. It has been isolated from Glycyrrhiza uralensis.
4-hydroxy-7-methoxy-2,3,8-trimethyl-3-(4-methylpent-3-enyl)-2H-benzo[g][1]benzofuran-6,9-dione
C22H26O5_4-[(3R)-5,7-Dimethoxy-6-(3-methyl-2-buten-1-yl)-3,4-dihydro-2H-chromen-3-yl]-1,3-benzenediol
4-hydroxy-7-methoxy-2,3,8-trimethyl-3-(4-methylpent-3-enyl)-2H-benzo[g][1]benzofuran-6,9-dione [IIN-based on: CCMSLIB00000849091]
4-hydroxy-7-methoxy-2,3,8-trimethyl-3-(4-methylpent-3-enyl)-2H-benzo[g][1]benzofuran-6,9-dione [IIN-based: Match]
Ala Gly His Ser
Ala Gly Ser His
Ala His Gly Ser
Ala His Ser Gly
Ala Pro Pro Ser
Ala Pro Ser Pro
Ala Ser Gly His
Ala Ser His Gly
Ala Ser Pro Pro
Gly Ala His Ser
Gly Ala Ser His
Gly Gly His Thr
Gly Gly Thr His
Gly His Ala Ser
Gly His Gly Thr
Gly His Ser Ala
Gly His Thr Gly
Gly Pro Pro Thr
Gly Pro Thr Pro
Gly Ser Ala His
Gly Ser His Ala
Gly Thr Gly His
Gly Thr His Gly
Gly Thr Pro Pro
His Ala Gly Ser
His Ala Ser Gly
His Gly Ala Ser
His Gly Gly Thr
His Gly Ser Ala
His Gly Thr Gly
His Ser Ala Gly
His Ser Gly Ala
His Thr Gly Gly
Pro Ala Pro Ser
Pro Ala Ser Pro
Pro Gly Pro Thr
Pro Gly Thr Pro
Pro Pro Ala Ser
Pro Pro Gly Thr
Pro Pro Ser Ala
Pro Pro Thr Gly
Pro Ser Ala Pro
Pro Ser Pro Ala
Pro Thr Gly Pro
Pro Thr Pro Gly
4-hydroxy-3,5-bis(1-methylethyl)phenyl glucuronide
4-hydroxy-2,6-bis(1-methylethyl)phenyl glucuronide
Ser Ala Gly His
Ser Ala His Gly
Ser Ala Pro Pro
Ser Gly Ala His
Ser Gly His Ala
Ser His Ala Gly
Ser His Gly Ala
Ser Pro Ala Pro
Ser Pro Pro Ala
Thr Gly Gly His
Thr Gly His Gly
Thr Gly Pro Pro
Thr His Gly Gly
Thr Pro Gly Pro
Thr Pro Pro Gly
2,3-Dinor-6,15-diketo-13,14-dihydro-20-carboxyl-PGF1a
Androsterone sulfate
C19H30O5S (370.18138500000003)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones A steroid sulfate that is the 3-sulfate of androsterone.
17β-Hydroxy-5α-androstan-3-one sulfate
C19H30O5S (370.18138500000003)
3alpha-hydroxy-5alpha-androstan-17-one 3-sulfate
C19H30O5S (370.18138500000003)
sodium chlorovulone II
C20H27NaO5 (370.17560920000005)
sodium chlorovulone III
C20H27NaO5 (370.17560920000005)
Cellulose gel
D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients D001697 - Biomedical and Dental Materials
Kanzonol R
Lorcainide
C22H27ClN2O (370.18118020000003)
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Etiocholanolone sulfate
C19H30O5S (370.18138500000003)
8-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,9-dihydro-1H-purine-2,6-dione
1-[(1-methylethyl)amino]-4-[(4-methylphenyl)amino]anthraquinone
Oxypendyl
C20H26N4OS (370.18272260000003)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-(3-oxo-1-octen-1-yl)-2H-cyclopenta[b]furan-2-one
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-phenyl-N-(phenylmethyl)- (9CI)
n,n-dimethyl-p-phenylenediamine sulfate
C16H26N4O4S (370.16746760000007)
3,6-BIS[(1,1-DIMETHYLETHYL)-9H-FLUOREN-9-YL]CHLORODIMETHYL-SILANE
METHYL 4-(2-(PYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE-6-CARBOXYLATE
C22H18N4O2 (370.14296879999995)
1,3-Diethyl-8-[(E)-2-(3-hydroxy-4-methoxyphenyl)vinyl]-7-methyl-3 ,7-dihydro-1H-purine-2,6-dione
(3AR,4R,5R,6AS)-2-OXO-4-((E)-3-OXOOCT-1-EN-1-YL)HEXAHYDRO-2H-CYCLOPENTA[B]FURAN-5-YL BENZOATE
Brivanib
A secondary alcohol resulting from the hydrolysis of the carboxylic ester group of brivanib alaninate. It is a dual VEGFR-2/FGFR-1 kinase inhibitor whose alanine prodrug, brivanib alaninate is currently under development as an oral agent for the treatment of cancer. C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-[(4-fluorophenyl)methyl]-N-propyl- (9CI)
2,6-bis(4-azidobenzylidene)-4-methylcyclohexanone
C21H18N6O (370.15420179999995)
(S)-4-(anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
N-(2-Fluoro-5-methylphenyl)-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea
1,3-dimethyl-5-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methylidene]-1,3-diazinane-2,4,6-trione
Colpormon
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Branebrutinib
C20H23FN4O2 (370.18049499999995)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Mepazine acetate
C21H26N2O2S (370.17148960000003)
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Telenzepine
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methyl-6-pyrrolo[2,1-f][1,2,4]triazinyl]oxy]-2-propanol
1-[4-(Cyclooctylamino)pyridin-3-yl]sulfonyl-3-ethylthiourea
Costatolide
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
Calanolide F
A natural product found in Calophyllum lanigerum var austrocoriaceum and Calophyllum teysmannii var inophylloide. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
7-Cyclopentyl-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine
3-methyl-N-[2-(4-morpholinyl)ethyl]-1-phenyl-5-thieno[2,3-c]pyrazolecarboxamide
7-[(E)-but-2-enyl]-3-methyl-8-(3-phenylpropylsulfanyl)purine-2,6-dione
ethyl 4-O-alpha-D-galactopyranosyl-beta-D-galactopyranoside
Disilane,1,1,2,2-tetramethyl-1,2-di-1-naphthalenyl-
Trimethylsilyl 2,6-bis[(trimethylsilyl)oxy]benzoate
C16H30O4Si3 (370.14518200000003)
Trimethylsilyl 3,4-bis(trimethylsilyloxy)benzoate
C16H30O4Si3 (370.14518200000003)
4-{[4-Amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-YL]amino}benzamide
C18H22N6O3 (370.17533019999996)
(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide
2,4-Diamino-6-[N-(3,4,5-trimethoxybenzyl)-N-methylamino]pyrido[2,3-D]pyrimidine
C18H22N6O3 (370.17533019999996)
3-[(4-Hydroxybenzoyl)amino]azepan-4-YL 4-hydroxybenzoate
RVX-208
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(3S,8R,9S,10S,13S,14S)-10,13-Dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl] hydrogen sulfate
C19H30O5S (370.18138500000003)
5beta-Androstan-3alpha-ol-17-one sulfate
C19H30O5S (370.18138500000003)
(2R,3R,4R,5R,6R)-5-{[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-6-(hydroxymethyl)-2-methoxyoxane-3,4-diol
1,4-bis-{[N-(1-imino-1-guanidino-methyl)]sulfanylmethyl}-3,6-dimethyl-benzene
4-Androsten-3beta,17beta-diol 17-sulfate
C19H30O5S (370.18138500000003)
Methyl (3R,3S,8S,10R)-2-oxospiro[1H-indole-3,12-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7-carboxylate
5-[4-(2-Furylcarbonyl)piperazino]-5-oxo-3-phenylpentanoic acid
6-[(2-fluorophenyl)methyl]-5-methyl-N-(3-methylbutyl)-7-oxo-1H-pyrazolo[1,5-a]pyrimidine-3-carboxamide
C20H23FN4O2 (370.18049499999995)
2-[2-fluoro-5-(4-methyl-1-piperazinyl)-4-nitrophenyl]-3,4-dihydro-1H-isoquinoline
C20H23FN4O2 (370.18049499999995)
6-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-(3-pyridinylmethyl)-4-quinazolinamine
C22H18N4O2 (370.14296879999995)
N-[2-(1-phenylethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]methanesulfonamide
1-cyclohexyl-3-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)thiourea
C20H26N4OS (370.18272260000003)
5-(1,3-Benzodioxol-5-ylmethylamino)-2-(4-morpholinyl)benzoic acid methyl ester
4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide
C17H26N2O5S (370.15623460000006)
4-[7-(4-Methylphenyl)-5-phenyl-4-pyrrolo[2,3-d]pyrimidinyl]morpholine
4-[7-(3-Methylphenyl)-5-phenyl-4-pyrrolo[2,3-d]pyrimidinyl]morpholine
4-[[[[2-(3-Pyridinyl)-1-piperidinyl]amino]-sulfanylidenemethyl]amino]benzoic acid methyl ester
1-(4-ethylphenyl)-2-methyl-N-(3-pyridinylmethyl)-5-benzimidazolecarboxamide
2-Amino-7-methyl-5-oxo-4-(2,4,5-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile
[(2R)-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-2-propanoyloxy-propyl] propanoate
C14H29NO8P+ (370.16307040000004)
2-Amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile
2-[[[2-[[(4-Methoxyphenyl)-oxomethyl]amino]phenyl]-oxomethyl]amino]-3-methylbutanoic acid
2-(3-chloro-4-fluorophenoxy)-N-[(3S)-1-(3,3-dimethylbutyl)-3-piperidinyl]acetamide
Cyclopropyl-[4-(2,7-dimethyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)-1-piperazinyl]methanone
C20H26N4OS (370.18272260000003)
N-[(E)-[2-(1-methylpyridin-1-ium-2-yl)cyclohexylidene]amino]-2,4-dinitroaniline
C18H20N5O4+ (370.15152200000006)
[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl][3-(3-amino-2-hydroxypropoxy)phenyl]methanone
N-ethyl-N-[[(2S,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
[(1R,5S)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-(2-pyrazinyl)methanone
3,4,5-Trihydroxy-6-[1-(4-methoxyphenyl)pentan-3-yloxy]oxane-2-carboxylic acid
N-[(2S,3R,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]propanamide
C18H24F2N2O4 (370.17040480000003)
N-ethyl-N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
C17H26N2O5S (370.15623460000006)
1-[(2S,3R)-6-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone
sodium 4R,12S-dihydroxy-9-oxo-5E,7Z,10Z,13Z-prostatetraenoate-cyclo[8,12]
C20H27NaO5 (370.17560920000005)
12-(4-ethoxyphenyl)-9,10,11a,12-tetrahydro-8H-benzo[b][4,7]phenanthrolin-11-one
N-[(E)-[(Z)-3-(furan-2-yl)-2-methylprop-2-enylidene]amino]-3-naphthalen-2-yl-1H-pyrazole-5-carboxamide
C22H18N4O2 (370.14296879999995)
[(3R,8R,9S,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] hydrogen sulfate
C19H30O5S (370.18138500000003)
2-[(6-amino-7H-purin-3-ium-8-yl)sulfanyl]-1-(4-phenylpiperazin-1-yl)ethanone
C17H20N7OS+ (370.14499700000005)
Trimethylsilyl 2,3-bis[(trimethylsilyl)oxy]benzoate
C16H30O4Si3 (370.14518200000003)
2-[2,3-Di(propanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium
C14H29NO8P+ (370.16307040000004)
2,3-Dihydro-1,1,3,3-tetramethyl-1,3-disilaphenalene-2-spiro-1,2-dihydronaphthalene
2-[(3-Acetyloxy-2-butanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C14H29NO8P+ (370.16307040000004)
Calanolide A
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
5alpha-Dihydrotestosterone sulfate
C19H30O5S (370.18138500000003)
A 3-oxo-5alpha-steroid that is 5alpha-dihydrotestosterone in which the hydroxy hydrogen at position 17 has been replaced by a sulfo group.
Epiandrosterone sulfate
C19H30O5S (370.18138500000003)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones A steroid sulfate that is the 3-sulfate of epiandrosterone.
3-Hydroxy-7-methoxy-1-pentyl-9-propyldibenzo[b,d]furan-2-carboxylic acid
alpha-D-Gal-(1->4)-beta-D-Gal-OEt
A glycoside that consists of ethyl beta-D-galactoside having an alpha-D-galactosyl residue at the 4-position.
(+)-calanolide A
An organic heterotetracyclic compound that is 11,12-dihydro-2H,6H,10H-dipyrano[2,3-f:2,3-h]chromen-2-one substituted by a hydroxy group at position 12, methyl groups at positions 6, 6, 10 and 11 and a propyl group at position 4 (the 10R,11S,12S stereoisomer). Isolated from Calophyllum lanigerum var austrocoriaceum and Calophyllum brasiliense, it exhibits potent activity against HIV-1 reverse transcriptase.
(-)-calanolide B
An organic heterotetracyclic compound that is 11,12-dihydro-2H,6H,10H-dipyrano[2,3-f:2,3-h]chromen-2-one substituted by a hydroxy group at position 12, methyl groups at positions 6, 6, 10 and 11 and a propyl group at position 4 (the 10S,11R,12S stereoisomer). Isolated from Calophyllum lanigerum var austrocoriaceum and Calophyllum brasiliense, it exhibits potent activity against HIV-1 reverse transcriptase.
Nitrocaramiphen (hydrochloride)
Nitrocaramiphen hydrochloride is a selective M1 receptor antagonist (Ki: 5.5 nM). Nitrocaramiphen Hydrochloride inhibits the hyperpolarizing effect of muscarine in the muscle fibers[1][2][3].
(3,4,5-trihydroxy-6-{[4-(4-hydroxyphenyl)butan-2-yl]oxy}oxan-2-yl)methyl acetate
(1r,2r,3s)-1,2-bis(acetyloxy)-1-[(2s)-6-oxo-2,3-dihydropyran-2-yl]heptan-3-yl acetate
4-hydroxy-7-methoxy-2,3,8-trimethyl-3-(4-methylpent-3-en-1-yl)-2h-naphtho[1,2-b]furan-6,9-dione
6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one
(2s)-2-hydroxy-1-[4-hydroxy-2-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-methoxyphenyl)propan-1-one
2-[(3,4-dimethoxyphenyl)methoxy]-7-methoxy-3-methyl-5-(prop-1-en-1-yl)-2,3-dihydro-1-benzofuran
1-hydroxy-5,5,13-trimethyl-4-(3-oxobutanoyl)-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-8,10,12(15)-triene-3,14-dione
(1r,8s,11r,15s)-6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione
(2r,3r)-7-methoxy-3-methyl-5-[(1e)-prop-1-en-1-yl]-2-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1-benzofuran
3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
5-[(1s,3ar,4s,6ar)-4-(3,4-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2h-1,3-benzodioxole
(2r,4as)-2,8,10-trihydroxy-2,5,5,9-tetramethyl-4,4a-dihydro-3h-6-oxatetraphene-7,12-dione
5-[(1r,3as,4r,6as)-4-(3,4-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2h-1,3-benzodioxole
(2r,2ar,4as,6r,7ar,7br)-3-formyl-6,7b-dimethyl-1h,2h,2ah,4ah,5h,6h,7h,7ah-cyclobuta[e]inden-2-yl 2,4-dihydroxy-6-methylbenzoate
4a,5,6,7,8-pentahydroxy-2,2-dimethyl-7-(3-methylbut-3-en-1-yn-1-yl)-hexahydro-1-benzopyran-3-yl acetate
(2s,3s,4r,6r,8s,11s)-6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione
(3s)-3-(2,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
methyl (2s,4r,5r,11r,12r)-14-oxo-5,11-bis(prop-1-en-2-yl)-3,13,16-trioxatetracyclo[10.2.1.1⁷,¹⁰.0²,⁴]hexadeca-1(15),7,9-triene-8-carboxylate
methyl (5s,11s)-3-methyl-7,10-dioxo-11-(prop-1-en-2-yl)-6,16-dioxatricyclo[11.2.1.1⁵,⁸]heptadeca-1(15),2,8(17),13-tetraene-14-carboxylate
7-methoxy-17,17-dimethyl-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5,7,9,13,19-hexaene-2,16-diol
(3s)-5,7-dihydroxy-3-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-2,3-dihydro-1-benzopyran-4-one
5,7-dihydroxy-3-[3-hydroxy-4-methoxy-2-(3-methylbut-2-en-1-yl)phenyl]-2,3-dihydro-1-benzopyran-4-one
(3s)-3-[3-hydroxy-2,4-dimethoxy-5-(2-methylbut-3-en-2-yl)phenyl]-3,4-dihydro-2h-1-benzopyran-7-ol
(2e)-1-{2,4-dihydroxy-3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-6-methoxyphenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one
(2r,3s,3as)-2-(2h-1,3-benzodioxol-5-yl)-5,7-dimethoxy-3-methyl-3a-(prop-2-en-1-yl)-2,3-dihydro-1-benzofuran-6-one
(2R,3R)-3,5-dihydroxy-7-methoxyflavanone3-(2-methyl)-butyrate
{"Ingredient_id": "HBIN006403","Ingredient_name": "(2R,3R)-3,5-dihydroxy-7-methoxyflavanone3-(2-methyl)-butyrate","Alias": "NA","Ingredient_formula": "C21H22O6","Ingredient_Smile": "CCC(C)C(=O)OC1C(OC2=CC(=CC(=C2C1=O)O)OC)C3=CC=CC=C3","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41731","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-hydroxy-2-[(e)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenylβ-d-glucopyranoside
{"Ingredient_id": "HBIN010450","Ingredient_name": "4-hydroxy-2-[(e)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C18H26O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10197","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-allyl-7-(3,4-dimethoxyphenyl)-2,3-dimethoxy-8-methyl-tricyclo[4.2.0.02,8]oct-3-en-5-one
{"Ingredient_id": "HBIN012182","Ingredient_name": "6-allyl-7-(3,4-dimethoxyphenyl)-2,3-dimethoxy-8-methyl-tricyclo[4.2.0.02,8]oct-3-en-5-one","Alias": "NA","Ingredient_formula": "C22H26O5","Ingredient_Smile": "CC12C(C3(C1C2(C(=CC3=O)OC)OC)CC=C)C4=CC(=C(C=C4)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "946","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
agarobiose dimethylacetal
{"Ingredient_id": "HBIN014820","Ingredient_name": "agarobiose dimethylacetal","Alias": "NA","Ingredient_formula": "C14H26O11","Ingredient_Smile": "COC(C(C1C(C(CO1)O)OC2C(C(C(C(O2)CO)O)O)O)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "702","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
alkannin angelate
{"Ingredient_id": "HBIN015181","Ingredient_name": "alkannin angelate","Alias": "NA","Ingredient_formula": "C21H22O6","Ingredient_Smile": "CC=C(C)C(=O)OC(CC=C(C)C)C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14236","TCMID_id": "910","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
α-o-methylcubebin
{"Ingredient_id": "HBIN015627","Ingredient_name": "\u03b1-o-methylcubebin","Alias": "NA","Ingredient_formula": "C21H22O6","Ingredient_Smile": "COC1C(C(CO1)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14257","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
β,β-dimethylacrylalkannin
{"Ingredient_id": "HBIN017982","Ingredient_name": "\u03b2,\u03b2-dimethylacrylalkannin","Alias": "beta,beta-dimethylacrylalkannin","Ingredient_formula": "C21H22O6","Ingredient_Smile": "CC(=CC(C)(C)C(C1=CC(=C2C(=O)C=CC(=O)C2=C1O)O)OC(=O)C=C)C","Ingredient_weight": "370.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15152;SMIT18985","TCMID_id": "25847;6301","TCMSP_id": "NA","TCM_ID_id": "6331","PubChem_id": "137321120","DrugBank_id": "NA"}
β-o-methylcubebin
{"Ingredient_id": "HBIN018214","Ingredient_name": "\u03b2-o-methylcubebin","Alias": "NA","Ingredient_formula": "C21H22O6","Ingredient_Smile": "COC1C(C(CO1)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14258","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(2-methylbut-3-en-2-yl)-2,3-dihydro-1-benzopyran-4-one
(2r,3r)-3,5-dihydroxy-2-(4-hydroxyphenyl)-7-methoxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2s)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(2-methylbut-3-en-2-yl)-2,3-dihydro-1-benzopyran-4-one
2-{[4-hydroxy-2-(1-hydroxy-2,2-dimethoxyethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3r)-3-(3-hydroxy-2,4-dimethoxyphenyl)-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol
15-(1,2-dihydroxypent-3-en-1-yl)-5-hydroxy-3,12-dimethyl-8,16-dioxatetracyclo[8.6.0.0²,⁷.0¹¹,¹⁵]hexadeca-1(10),2,4,6,13-pentaen-9-one
3-(3-hydroxy-2,4-dimethoxyphenyl)-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol
(2s,3s,3ar)-2-(2h-1,3-benzodioxol-5-yl)-5,7-dimethoxy-3-methyl-3a-(prop-2-en-1-yl)-2,3-dihydro-1-benzofuran-6-one
4-(2h-1,3-benzodioxol-5-ylmethyl)-3-[(3,4-dimethoxyphenyl)methyl]oxolan-2-one
(2s,3r)-5-methoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)-3-methyl-7-(prop-2-en-1-yl)-2,3-dihydro-1,4-benzodioxine
(2s)-5,7-dihydroxy-8-(2-hydroxy-3-methylbut-2-en-1-yl)-2-(4-methoxyphenyl)-2,3-dihydro-1-benzopyran-4-one
8-(3,4-dimethoxy-1,3-dihydro-2-benzofuran-1-yl)-3,7-dihydroxy-3-methyl-2,4-dihydronaphthalen-1-one
(2r,3s,4r)-4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2,3-dimethyl-3,4-dihydro-2h-naphthalen-1-one
(2z)-6-methyl-2-{2-[(5-methyl-2-oxochromen-4-yl)oxy]ethylidene}hept-5-en-1-yl acetate
2,6-dihydroxy-4-methoxy-3-[(2e)-3-phenylprop-2-enoyl]phenyl (2r)-2-methylbutanoate
3-formyl-6,7b-dimethyl-1h,2h,2ah,4ah,5h,6h,7h,7ah-cyclobuta[e]inden-2-yl 2,4-dihydroxy-6-methylbenzoate
5-hydroxy-11-methoxy-13-pentyl-3-propyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaene-4-carboxylic acid
5,7-dihydroxy-2-[4-hydroxy-3-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-2,3-dihydro-1-benzopyran-4-one
(2s,11s,16s)-7-methoxy-17,17-dimethyl-4,12,18-trioxapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-1(21),5,7,9,13,19-hexaene-2,16-diol
(1s,2s,3r,4r,6r,8r,11r,13s,15r)-6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione
methyl (2e,5r,11s)-3-methyl-7,10-dioxo-11-(prop-1-en-2-yl)-6,16-dioxatricyclo[11.2.1.1⁵,⁸]heptadeca-1(15),2,8(17),13-tetraene-14-carboxylate
8-(dec-9-en-1-yl)-3,4-dihydroxy-2,6-dioxo-1,7-dioxaspiro[4.4]nonane-4-carboxylic acid
2-(2h-1,3-benzodioxol-5-yl)-5,7-dimethoxy-3-methyl-3a-(prop-2-en-1-yl)-2,3-dihydro-1-benzofuran-6-one
(2r)-7-hydroxy-8-[(1z)-3-hydroxy-3-methylbut-1-en-1-yl]-2-(4-hydroxyphenyl)-5-methoxy-2,3-dihydro-1-benzopyran-4-one
2,11,12-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl propanoate
(2s,3s)-5-methoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)-3-methyl-7-(prop-2-en-1-yl)-2,3-dihydro-1-benzofuran-6-ol
(2e)-1-[4-hydroxy-2-(2-hydroxypropan-2-yl)-6-methoxy-2,3-dihydro-1-benzofuran-7-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
5-[(4r)-4-(3,4-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2h-1,3-benzodioxole
(3r)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-{[(1s)-1-carboxy-2-(3h-imidazol-4-yl)ethyl]amino}butanoic acid
16-hydroxy-6-(2-hydroxy-3-methylbut-3-en-1-yl)-7-methoxy-14-methyl-2,10-dioxatricyclo[10.4.0.0³,⁸]hexadeca-1(16),3,5,7,12,14-hexaen-9-one
(2r,3r,3as)-2-(2h-1,3-benzodioxol-5-yl)-5,7-dimethoxy-3-methyl-3a-(prop-2-en-1-yl)-2,3-dihydro-1-benzofuran-6-one
(3r)-5,7-dihydroxy-3-[3-hydroxy-4-methoxy-2-(3-methylbut-2-en-1-yl)phenyl]-2,3-dihydro-1-benzopyran-4-one
(2e)-1-{3-[(2s)-2-hydroperoxy-3-methylbut-3-en-1-yl]-2-hydroxy-4-methoxyphenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one
(10s,11r,12s)-7,8,10,11-tetramethoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraene
2-[4-hydroxy-2-(4-hydroxy-3-methylbut-2-en-1-yl)-5-methylphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,3r,6r,10r)-2-(2h-1,3-benzodioxol-5-yl)-7,8-dimethoxy-10-(prop-2-en-1-yl)-5-oxatricyclo[4.3.1.0³,¹⁰]dec-7-en-9-one
5-[(1r,3ar,4s,6ar)-4-(3,4-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2h-1,3-benzodioxole
4-hydroxy-7-methoxy-2,3,6-trimethyl-3-(4-methylpent-3-en-1-yl)-2h-naphtho[2,3-b]furan-5,8-dione
9-{[(2e)-7-hydroxy-3,7-dimethyl-6-oxooct-2-en-1-yl]oxy}furo[3,2-g]chromen-7-one
(1s,11r,12r,17r)-12-acetyl-6-hydroxy-10-(methoxycarbonyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraen-14-ium-14-olate
2-(3,4-dimethoxyphenyl)ethenyl 3-(3,4-dimethoxyphenyl)prop-2-enoate
4-[6-hydroxy-3-(hydroxymethyl)-5-methoxy-7-(3-methylbut-2-en-1-yl)-1-benzofuran-2-yl]benzene-1,3-diol
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r)-4-(4-hydroxyphenyl)butan-2-yl]oxy}oxan-2-yl]methyl acetate
(10r,11s,12s)-7,8,10,11-tetramethoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraene
7-acetyl-15-hydroxy-8,12-dimethyl-18-oxapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),16-diene-2,19-dione
(2s,3r,4s,5r,6r)-2-{[(2s,3r,4s)-4-hydroxy-2-[(1s)-1-hydroxy-2,2-dimethoxyethyl]oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r)-4-hydroxy-7-methoxy-2,3,6-trimethyl-3-(4-methylpent-3-en-1-yl)-2h-naphtho[2,3-b]furan-5,8-dione
(2s)-2-[3-(cyanomethyl)-4-methoxy-1h-indol-7-yl]-2-(4-methoxy-1h-indol-3-yl)acetonitrile
C22H18N4O2 (370.14296879999995)
4-[(1e)-1-(3,4-dimethoxyphenyl)prop-1-en-2-yl]-4,5-dimethoxy-2-(prop-2-en-1-yl)cyclohexa-2,5-dien-1-one
(10r,11r,12s)-12-hydroxy-4-isopropyl-6,6,10,11-tetramethyl-11,12-dihydro-10h-1,5,9-trioxatriphenylen-2-one
(2s,3r,4s,5s,6r)-2-{4-hydroxy-2-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-5-methylphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1'r,3s,4's,8'r,9's)-1,6-dimethoxy-2-oxo-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-6'-ene-7'-carbaldehyde
(2e,7r)-7-{[(2e,4s,7r)-7-(acetyloxy)-4-hydroxyoct-2-enoyl]oxy}-4-oxooct-2-enoic acid
3-[1,4,7-trihydroxy-9-(hydroxymethyl)-10-oxo-3h,6h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-3-yl]propanoic acid
1,8-dihydroxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene-2-carboxylic acid
(1s,2r,3r,4as)-3-chloro-2-ethenyl-8-[(hydroxymethylidene)amino]-1-isocyano-2,10,10-trimethyl-3,4,4a,9a-tetrahydro-1h-anthracen-9-one
(10r,11s,12r)-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-10h-1,5,9-trioxatriphenylen-2-one
(1r,4r,7s,8s,12r,15s)-7-acetyl-15-hydroxy-8,12-dimethyl-18-oxapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),16-diene-2,19-dione
6-(3-ethoxy-3-methylbut-1-en-1-yl)-5-methoxy-2,2-dimethylpyrano[2,3-h]chromen-8-one
(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-yl (2e,6e)-deca-2,6-dien-4-ynoate
4-[1-(3,4-dimethoxyphenyl)prop-1-en-2-yl]-4,5-dimethoxy-2-(prop-2-en-1-yl)cyclohexa-2,5-dien-1-one
(3r,4ar,5s,6s,7r,8s,8as)-4a,5,6,7,8-pentahydroxy-2,2-dimethyl-7-(3-methylbut-3-en-1-yn-1-yl)-hexahydro-1-benzopyran-3-yl acetate
3-[(3r,9s,14as)-1,4,7-trihydroxy-9-(hydroxymethyl)-10-oxo-3h,6h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-3-yl]propanoic acid
5-[4-(2h-1,3-benzodioxol-5-yl)-1-ethoxy-2,3-dimethylbutyl]-2h-1,3-benzodioxole
4-[(3s)-5,7-dimethoxy-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-3-yl]benzene-1,3-diol
3,5,6,7,8-pentahydroxy-2,2-dimethyl-7-(3-methylbut-3-en-1-yn-1-yl)-hexahydro-1-benzopyran-4a-yl acetate
(3r,5r)-8-(dec-9-en-1-yl)-3,4-dihydroxy-2,6-dioxo-1,7-dioxaspiro[4.4]nonane-4-carboxylic acid
(2r,3r,9s,10s)-12-methyl-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-trien-10-yl acetate
6-[(1e)-3-ethoxy-3-methylbut-1-en-1-yl]-5-methoxy-2,2-dimethylpyrano[2,3-h]chromen-8-one
7-methoxy-3-methyl-5-(prop-1-en-1-yl)-2-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1-benzofuran
7-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-5-hydroxy-2-methoxy-6-methylnaphthalene-1,4-dione
(2s,3r,4r)-4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2,3-dimethyl-3,4-dihydro-2h-naphthalen-1-one
2-{1-[(1-hydroxypropylidene)amino]ethyl}-n-[2-(1h-indol-3-yl)ethyl]-1,3-thiazole-4-carboximidic acid
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2s)-4-(4-hydroxyphenyl)butan-2-yl]oxy}oxan-2-yl]methyl acetate
(2z,4e)-5-(3,4-dimethoxyphenyl)-2-[(3,4-dimethoxyphenyl)methylidene]pent-4-en-1-ol
4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2,3-dimethyl-3,4-dihydro-2h-naphthalen-1-one
(2r,3r)-2-[(3,4-dimethoxyphenyl)methoxy]-7-methoxy-3-methyl-5-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran
5-hydroxy-8,8-dimethyl-6-[(2r)-2-methylbutanoyl]-4-propylpyrano[2,3-h]chromen-2-one
(4s)-4-[(1e)-1-(3,4-dimethoxyphenyl)prop-1-en-2-yl]-4,5-dimethoxy-2-(prop-2-en-1-yl)cyclohexa-2,5-dien-1-one
9-(2h-1,3-benzodioxol-4-yl)-1-(2,6-dihydroxyphenyl)nonan-1-one
6-methyl-2-{2-[(5-methyl-2-oxochromen-4-yl)oxy]ethylidene}hept-5-en-1-yl acetate
2-(2-hydroxypropoxy)-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol
(1'r,3s,4's,7'r,8's)-6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one
7-(3,4-dimethoxyphenyl)-2,3-dimethoxy-8-methyl-6-(prop-2-en-1-yl)tricyclo[4.2.0.0²,⁸]oct-3-en-5-one
3-chloro-2-ethenyl-8-[(hydroxymethylidene)amino]-1-isocyano-2,10,10-trimethyl-3,4,4a,9a-tetrahydro-1h-anthracen-9-one
(2e,4r)-3,7-dimethyl-1-[(5-methyl-2-oxochromen-4-yl)oxy]octa-2,6-dien-4-yl acetate
(4z)-3,5-dibenzyl-3-hydroxy-4-(phenylmethylidene)oxolan-2-one
(2r,3r,8s,9r)-12-methyl-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-trien-8-yl acetate
2-(3-hydroxy-5-methoxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol
1,2-bis(acetyloxy)-1-(6-oxo-2,3-dihydropyran-2-yl)heptan-3-yl acetate
3,7-dimethyl-1-[(5-methyl-2-oxochromen-4-yl)oxy]octa-2,6-dien-4-yl acetate
6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione
9-(2h-1,3-benzodioxol-5-yl)-1-(2,6-dihydroxyphenyl)nonan-1-one
(2s,3r)-2-{[(2s)-2-amino-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-{[(1s)-1-carboxy-2-(3h-imidazol-4-yl)ethyl]amino}butanoic acid
12-methyl-5-oxo-2,9-bis(prop-1-en-2-yl)-4,14-dioxatricyclo[9.2.1.1³,⁶]pentadeca-1(13),6(15),11-trien-8-yl acetate
(3r)-3-[2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-5-methoxy-3,4-dihydro-2h-1-benzopyran-7-ol
5-hydroxy-8,8-dimethyl-6-(2-methylbutanoyl)-4-propylpyrano[2,3-h]chromen-2-one
(1s,2s,3r,4r,6r,8r,11r,13s)-6-methyl-2-(2-oxopropyl)-16-oxapentacyclo[13.2.2.0¹,¹³.0³,¹¹.0⁴,⁸]nonadec-9-ene-7,17,18-trione
2-(3,5-dimethoxyphenyl)-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-5,7-diol
6-[(2r,3r,4r,5s)-5-(3,4-dimethoxyphenyl)-3,4-dimethyloxolan-2-yl]-2,3-dihydro-1,4-benzodioxine
(2r,3r,4s,5s,6r)-2-[(2s)-2-hydroxypropoxy]-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2r)-2-(3-hydroxy-5-methoxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-ol
(10r,11r,12s)-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-10h-1,5,9-trioxatriphenylen-2-one
(11r,12s)-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-11,12-dihydro-10h-1,5,9-trioxatriphenylen-2-one
methyl 3-(acetyloxy)-5-[(2-methylbutanoyl)oxy]-4-(propanoyloxy)cyclohex-1-ene-1-carboxylate
5-hydroxy-11-methoxy-3-pentyl-13-propyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaene-4-carboxylic acid
(3s)-3-{[6-(1h-indol-3-ylmethyl)pyrazin-2-yl]methyl}indole-2,3-diol
C22H18N4O2 (370.14296879999995)